PVR and liver cancer: Wang designed a novel polymerized nanoparticle that targets lncRNA INK4 as well as T cell immune receptors with Ig and ITIM domains (TIGIT)/poliovirus receptors (PVR) to inhibit liver cancer (Wang et al., 2021b).